| 2024 | Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
| BMC GASTROENTEROLOGY |
| 2024 | Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet's Disease
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2024 | Genome-wide association analysis reveals the associations of NPHP4, TYW1-AUTS2 and SEMA6D for Behçet's disease and HLA-B*46:01 for its intestinal involvement | DIGESTIVE AND LIVER DISEASE |
| 2024 | Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
| YONSEI MEDICAL JOURNAL |
| 2024 | Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| 2024 | Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea
| INTESTINAL RESEARCH |
| 2024 | Impact of age at diagnosis on long-term prognosis in patients with intestinal Behçet's disease | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2024 | Effectiveness and Tolerability of Methotrexate Combined with Biologics in Patients with Crohn's Disease: A Multicenter Observational Study | DIGESTIVE DISEASES AND SCIENCES |
| 2024 | A Comprehensive Understanding of Post-Translational Modification of Sox2 via Acetylation and O-GlcNAcylation in Colorectal Cancer
| CANCERS |
| 2024 | Risk factors for post-polypectomy bleeding in patients with end-stage renal disease undergoing colonoscopic polypectomy | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
| 2024 | New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases
| THERAPEUTIC ADVANCES IN GASTROENTEROLOGY |
| 2023 | Effectiveness and safety of adalimumab in patients with intestinal Behçet’s disease: a real-world prospective observational study in South Korea
| BMC GASTROENTEROLOGY |
| 2023 | Clinical importance of weight gain and associated factors in patients with moderate to severe ulcerative colitis: results from the MOSAIK cohort in Korea
| BMC GASTROENTEROLOGY |
| 2023 | Downregulation of Heat Shock Protein 72 Contributes to Fibrostenosis in Crohn's Disease
| GUT AND LIVER |
| 2023 | Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
| CELL COMMUNICATION AND SIGNALING |
| 2023 | Clinical characteristics and risk factors related to polyposis recurrence and advanced neoplasm development among patients with non-hereditary colorectal polyposis
| INTESTINAL RESEARCH |
| 2023 | The global, regional, and national burden of inflammatory bowel diseases, 1990-2019: A systematic analysis for the global burden of disease study 2019 | DIGESTIVE AND LIVER DISEASE |
| 2023 | Efficacy and Safety of Infliximab in Intestinal Behçet's Disease: A Multicenter, Phase 3 Study (BEGIN)
| GUT AND LIVER |
| 2023 | Novel Histone Deacetylase 6 Inhibitor Confers Anti-inflammatory Effects and Enhances Gut Barrier Function
| GUT AND LIVER |
| 2023 | Characteristics and Treatment Outcomes of Transition among Patients with Inflammatory Bowel Disease
| YONSEI MEDICAL JOURNAL |
| 2023 | Effectiveness and tolerability of methotrexate monotherapy in Crohn’s disease patients: a multicenter observational study
| THERAPEUTIC ADVANCES IN GASTROENTEROLOGY |
| 2023 | Bifidobacterium breve CBT BR3 is effective at relieving intestinal inflammation by augmenting goblet cell regeneration | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Validation of the simplified magnetic resonance index of activity by using DWI without gadolinium enhancement to evaluate bowel inflammation in Crohn's disease | EUROPEAN RADIOLOGY |
| 2023 | Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancer | CANCER GENE THERAPY |
| 2023 | Early Infliximab Trough Levels Predict the Long-term Efficacy of Infliximab in a Randomized Controlled Trial in Patients with Active Crohn's Disease Comparing, between CT-P13 and Originator Infliximab
| GUT AND LIVER |
| 2023 | Feasibility of a Clinical Decision Support Tool for Ustekinumab to Predict Clinical Remission and Relapse in Patients With Crohn's Disease: A Multicenter Observational Study | INFLAMMATORY BOWEL DISEASES |
| 2023 | COVID-19 susceptibility and clinical outcomes in inflammatory bowel disease: An updated systematic review and meta-analysis
| REVIEWS IN MEDICAL VIROLOGY |
| 2023 | Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Behçet's disease
| ARTHRITIS RESEARCH & THERAPY |
| 2023 | Long-term clinical outcomes of intestinal Behçet's disease: A 30-year cohort study at a tertiary hospital in South Korea | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | TRIM40 is a pathogenic driver of inflammatory bowel disease subverting intestinal barrier integrity
| NATURE COMMUNICATIONS |
| 2023 | Risk Factors for Surgery in Patients with Intestinal Behçet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
| YONSEI MEDICAL JOURNAL |
| 2023 | Past, present, and future of Intestinal Research
| INTESTINAL RESEARCH |
| 2023 | Factors associated with the prescription of probiotics in patients with inflammatory bowel disease: a cross-sectional study
| Journal of Yeungnam Medical Science |
| 2023 | Comparing the efficacy of different methods of faecal microbiota transplantation via oral capsule, oesophagogastroduodenoscopy, colonoscopy, or gastric tube | JOURNAL OF HOSPITAL INFECTION |
| 2023 | The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
| INTESTINAL RESEARCH |
| 2023 | Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Dise | GUT AND LIVER |
| 2022 | Corticosteroids and Mesalamine Versus Corticosteroids for Acute Severe Ulcerative Colitis: A Randomized Controlled Trial | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2022 | Aminoclay Nanoparticles Induce Anti-Inflammatory Dendritic Cells to Attenuate LPS-Elicited Pro-Inflammatory Immune Responses
| MOLECULES |
| 2022 | Clinical Characteristics of Korean Patients with Elderly-Onset Crohn's Disease: Results from the Prospective CONNECT Study
| GUT AND LIVER |
| 2022 | Microbial Modulation in Inflammatory Bowel Diseases
| IMMUNE NETWORK |
| 2022 | Clinical Features and Long-term Prognosis of Crohn's Disease in Korea: Results from the Prospective CONNECT Study
| GUT AND LIVER |
| 2022 | Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis
| GUT AND LIVER |
| 2022 | Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2022 | Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
| GUT AND LIVER |
| 2022 | Application of Multigene Panel Testing in Patients With High Risk for Hereditary Colorectal Cancer: A Descriptive Report Focused on Genotype-Phenotype Correlation | DISEASES OF THE COLON & RECTUM |
| 2022 | Tumor-Suppressive Effect of Metformin via the Regulation of M2 Macrophages and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment of Colorectal Cancer
| CANCERS |
| 2022 | A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome | HEPATOLOGY |
| 2022 | Smad4 and p53 synergize in suppressing autochthonous intestinal cancer
| CANCER MEDICINE |
| 2022 | Efficient gene transfection to lung cancer cells via Folate-PEI-Sorbitol gene transporter
| PLOS ONE |
| 2022 | Radiology plus ileocolonoscopy versus radiology alone in Crohn’s disease: prognosis prediction and mutual agreement
| KOREAN JOURNAL OF INTERNAL MEDICINE |
http://orcid.org/0000-0002-2282-8904
(35200350500)
